药品
医学
药物输送
联合疗法
行动地点
化疗
药理学
癌症
癌症治疗
联合化疗
抗药性
癌症化疗
癌症治疗
靶向给药
纳米技术
材料科学
内科学
生物
微生物学
作者
Che‐Ming Jack Hu,Santosh Aryal,Liangfang Zhang
出处
期刊:Therapeutic Delivery
[Newlands Press Ltd]
日期:2010-08-01
卷期号:1 (2): 323-334
被引量:539
摘要
Combination chemotherapy and nanoparticle drug delivery are two areas that have shown significant promise in cancer treatment. Combined therapy of two or more drugs promotes synergism among the different drugs against cancer cells and suppresses drug resistance through distinct mechanisms of action. Nanoparticle drug delivery, on the other hand, enhances therapeutic effectiveness and reduces side effects of the drug payloads by improving their pharmacokinetics. These two active research fields have been recently merged to further improve the efficacy of cancer therapeutics. This review article summarizes the recent efforts in developing nanoparticle platforms to concurrently deliver multiple types of drugs for combination chemotherapy. We also highlight the challenges and design specifications that need to be considered in optimizing nanoparticle-based combination chemotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI